IS8007A - 4-(2-fenýlsúlfanýl-fenýl)-1,2,3,6-tetrahýdrópýridín afleiður sem serótónín endurupptöku hindrar - Google Patents

4-(2-fenýlsúlfanýl-fenýl)-1,2,3,6-tetrahýdrópýridín afleiður sem serótónín endurupptöku hindrar

Info

Publication number
IS8007A
IS8007A IS8007A IS8007A IS8007A IS 8007 A IS8007 A IS 8007A IS 8007 A IS8007 A IS 8007A IS 8007 A IS8007 A IS 8007A IS 8007 A IS8007 A IS 8007A
Authority
IS
Iceland
Prior art keywords
phenylsulfanyl
phenyl
serotonin reuptake
inhibit serotonin
tetrahydropyridine derivatives
Prior art date
Application number
IS8007A
Other languages
English (en)
Inventor
Püschl Ask
Bang-Andersen Benny
Jørgensen Morten
Juhl Karsten
Ruhland Thomas
Andersen Kim
Kehler Jan
Original Assignee
H. Lundbeck A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35432910&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IS8007(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by H. Lundbeck A/S filed Critical H. Lundbeck A/S
Publication of IS8007A publication Critical patent/IS8007A/is

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
IS8007A 2003-04-04 2005-08-29 4-(2-fenýlsúlfanýl-fenýl)-1,2,3,6-tetrahýdrópýridín afleiður sem serótónín endurupptöku hindrar IS8007A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200300518 2003-04-04
PCT/DK2004/000243 WO2004087662A1 (en) 2003-04-04 2004-04-02 4-(2-phenylsulfanyl-phenyl)-1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors

Publications (1)

Publication Number Publication Date
IS8007A true IS8007A (is) 2005-08-29

Family

ID=35432910

Family Applications (1)

Application Number Title Priority Date Filing Date
IS8007A IS8007A (is) 2003-04-04 2005-08-29 4-(2-fenýlsúlfanýl-fenýl)-1,2,3,6-tetrahýdrópýridín afleiður sem serótónín endurupptöku hindrar

Country Status (27)

Country Link
US (1) US20070173522A1 (is)
EP (1) EP1613594B1 (is)
JP (1) JP2006522029A (is)
KR (1) KR20060021825A (is)
CN (1) CN100384822C (is)
AR (1) AR043964A1 (is)
AT (1) ATE390413T1 (is)
AU (1) AU2004226319A1 (is)
BR (1) BRPI0408453A (is)
CA (1) CA2521172A1 (is)
CL (1) CL2004000730A1 (is)
CO (1) CO5700777A2 (is)
DE (1) DE602004012724T2 (is)
DK (1) DK1613594T3 (is)
EA (1) EA009282B1 (is)
ES (1) ES2301979T3 (is)
HR (1) HRP20080243T3 (is)
IS (1) IS8007A (is)
MX (1) MXPA05010678A (is)
NO (1) NO20055205L (is)
NZ (1) NZ541944A (is)
PL (1) PL1613594T3 (is)
PT (1) PT1613594E (is)
SI (1) SI1613594T1 (is)
UA (1) UA81300C2 (is)
WO (1) WO2004087662A1 (is)
ZA (1) ZA200507182B (is)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20080478T3 (hr) 2003-04-04 2009-02-28 H. Lundbeck A/S Derivati 4-(2-fenilsulfanil-fenil)-piperidina kaoinhibitori ponovne pohrane serotonina
US8685924B2 (en) 2004-08-25 2014-04-01 Takeda Pharmaceutical Company Limited Preventives/remedies for stress urinary incontinence and method of screening the same
EP2018863B9 (en) 2006-05-16 2015-02-18 Takeda Pharmaceutical Company Limited Fused heterocyclic compound and use thereof
EP2789338A3 (en) 2007-11-15 2015-01-14 Takeda Pharmaceutical Company Limited Condensed pyridine derivate and use thereof
UA98698C2 (en) * 2008-03-03 2012-06-11 Х. Луннбек А/С Phenylsulfanylphenyl-piperidines and process for the preparation thereof
US20120253036A1 (en) 2009-12-11 2012-10-04 Yukinori Nagakura Agent for treating fibromyalgia
EP2930171A1 (en) * 2014-04-07 2015-10-14 LEK Pharmaceuticals d.d. Synthesis of vortioxetine via (2,4-dimethylphenyl)(2-iodophenyl)sulfane intermediate
CN105294554B (zh) * 2015-11-18 2017-11-07 乳源瑶族自治县大众药品贸易有限公司 苯基哌嗪衍生物及其使用方法和用途
US20210052600A1 (en) 2017-12-27 2021-02-25 Takeda Pharmaceutical Company Limited Therapeutic agents for stress urinary incontinence and incotinence of feces

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3803143A (en) * 1969-09-08 1974-04-09 Eisai Co Ltd 6-amino alkylene 6,7-dihydro-5h-dibenzo (b,g),(1,5)thiazocines
US4018830A (en) * 1969-09-22 1977-04-19 Merck & Co., Inc. Phenylthioaralkylamines
US4055665A (en) * 1974-11-25 1977-10-25 Merck & Co., Inc. Treating arrythmia with phenylthioaralkylamines
US4066654A (en) * 1975-04-16 1978-01-03 G. D. Searle & Co. 1-triarylalkyl-4-phenyl-4-piperidine carboxylic acids and derivatives
US4056632A (en) * 1975-07-21 1977-11-01 Burroughs Wellcome Co. 2-Hydroxymethyl-2'-aminomethyl-diphenylsulfides and method of use
US4241071A (en) * 1977-01-27 1980-12-23 American Hoechst Corporation Antidepressant (α-phenyl-2-tolyl)azacycloalkanes
DE2802306A1 (de) * 1977-01-27 1978-08-10 Hoechst Ag Azacycloalkane, azacycloalkene und ihre derivate
US4198419A (en) * 1979-01-10 1980-04-15 American Hoechst Corporation Phenylthiophenylpiperidines
US4198417A (en) * 1979-01-10 1980-04-15 American Hoechst Corporation Phenoxyphenylpiperidines
GB8912971D0 (en) * 1989-06-06 1989-07-26 Wellcome Found Halogen substituted diphenylsulfides
US6410736B1 (en) * 1999-11-29 2002-06-25 Pfizer Inc. Biaryl ether derivatives useful as monoamine reuptake inhibitors
WO2001027068A1 (en) * 1999-10-13 2001-04-19 Pfizer Products Inc. Biaryl ether derivatives useful as monoamine reuptake inhibitors
PL199351B1 (pl) * 1999-12-30 2008-09-30 Lundbeck & Co As H Związki pochodne fenylopiperazyny, zawierająca je kompozycja farmaceutyczna i ich zastosowanie
US6436938B1 (en) * 2001-01-22 2002-08-20 Pfizer Inc. Combination treatment for depression
US20020107244A1 (en) * 2001-02-02 2002-08-08 Howard Harry R. Combination treatment for depression
UA81749C2 (uk) * 2001-10-04 2008-02-11 Х. Луннбек А/С Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну

Also Published As

Publication number Publication date
MXPA05010678A (es) 2005-12-12
AR043964A1 (es) 2005-08-17
CO5700777A2 (es) 2006-11-30
SI1613594T1 (sl) 2008-08-31
EA009282B1 (ru) 2007-12-28
NO20055205L (no) 2005-11-04
EP1613594A1 (en) 2006-01-11
ZA200507182B (en) 2006-12-27
WO2004087662A1 (en) 2004-10-14
BRPI0408453A (pt) 2006-04-04
AU2004226319A1 (en) 2004-10-14
CL2004000730A1 (es) 2005-02-18
UA81300C2 (en) 2007-12-25
HRP20080243T3 (hr) 2009-04-30
JP2006522029A (ja) 2006-09-28
ES2301979T3 (es) 2008-07-01
PT1613594E (pt) 2008-07-01
KR20060021825A (ko) 2006-03-08
HK1090051A1 (en) 2006-12-15
DK1613594T3 (da) 2008-07-14
CN100384822C (zh) 2008-04-30
PL1613594T3 (pl) 2008-09-30
DE602004012724D1 (de) 2008-05-08
DE602004012724T2 (de) 2009-04-09
CN1777585A (zh) 2006-05-24
NZ541944A (en) 2008-05-30
US20070173522A1 (en) 2007-07-26
ATE390413T1 (de) 2008-04-15
CA2521172A1 (en) 2004-10-14
EP1613594B1 (en) 2008-03-26
EA200501579A1 (ru) 2006-04-28

Similar Documents

Publication Publication Date Title
DE60233608D1 (de) Phenylpiperidinderivate als Serotonin-Wiederaufnahmehemmer
HUS1900034I1 (hu) 6,7-telítetlen-7-karbamoil-szubsztituált morfinán-származékok
IS6704A (is) Fenoxýbensýlamínafleiður sem valvísir serótónín endurupptöku hindrar
ATE292128T1 (de) Piperidinderivate als neurokinin 1 antagonisten
ZA200610666B (en) Piperidine derivatives as NK, antagonists
NO20054607D0 (no) Nitrogenholdig heterosyklisk derivat som har 2,6-disubstituert styryl
IS8007A (is) 4-(2-fenýlsúlfanýl-fenýl)-1,2,3,6-tetrahýdrópýridín afleiður sem serótónín endurupptöku hindrar
DE602004010385D1 (de) 3,4-disubstituierte 1,2,3,4-tetrahydropyridinderivate
DK1656305T3 (da) Ny indretning
IL172541A0 (en) 2-hydroxymethyl-3,4,5-trihydroxy-1-(4-pentlyoxybenzyl) piperidine as glucosyliceramide synthase (gcs)
IL182538A0 (en) 1,5-diheterocycle-1h-triazole derivative
IS7901A (is) 4-(2-Fenýloxýfenýl)-píperidín eða -1,2,3,6-tetrahýdrópýridín afleiður sem serótónín endurupptöku hindrar
NL1030010A1 (nl) 4-Amino-gesubstitueerde-2-gesubstitueerde-1,2,3,4- tetrahydrochinolineverbindingen.
NO20055002D0 (no) Benzol[1,2,5]tiadiazolforbindelser
DK1315700T3 (da) Substituerede 4-phenyl-1-(1-phenylcyclohexyl)-1,2,3,6-tetrahydropyridiner
DE602004005048D1 (de) 2-methoxymethyl-3-(3,4-dichlorophenyl)-8-azabicyclo ä3.2.1üoctantartrat-salze
TWI315670B (en) Substituted aryl 1,4-pyrazine derivatives
ATE441647T1 (de) N-amidderivate von 8-azabicycloä3.2.1üoct-3-yl als ccr1-antagonisten
IS7996A (is) 4-(2-fenýlsúlfanýl-fenýl)-píperidín afleiður sem serótónín endurupptöku hindrar
DE602005017152D1 (de) Neue 2,6-diaminopyridin-3-on-derivate
NO20054067D0 (no) Nye substituerte 2,3-benzodiazepinderivater.
PT1912956E (pt) Sais metálicos de 2'-(1h-tetrazol-5-ilo)-1,1'-bifenilo-4- carboxaldeído
IS2815B (is) 2-(1H-indólýlsúlfanýl)-bensýlamínafleiður sem valvís serótónín endurupptökuhindri (SSRI).
ITMI20021328A1 (it) Nuove piperazine 1,4 - disostituite
EP1681284A4 (en) AROMATIC POLYAMINE DERIVATIVE